| Company/Division name | Fujifilm Diosynth Biotechnologies |
| Parent company | Fujifilm Corporation |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2022 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | College Station |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | biologics, vaccines, advanced therapies |
| What domestic positive factors made reshoring more attractive? | Skilled workforce availability/training |